These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cerebral perfusion in early and late opiate withdrawal: a technetium-99m-HMPAO SPECT study. Rose JS; Branchey M; Buydens-Branchey L; Stapleton JM; Chasten K; Werrell A; Maayan ML Psychiatry Res; 1996 May; 67(1):39-47. PubMed ID: 8797241 [TBL] [Abstract][Full Text] [Related]
5. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Prosser J; London ED; Galynker II Drug Alcohol Depend; 2009 Oct; 104(3):228-40. PubMed ID: 19608356 [TBL] [Abstract][Full Text] [Related]
6. Age-related changes in brain perfusion of normal subjects detected by 99mTc-HMPAO SPECT. Krausz Y; Bonne O; Gorfine M; Karger H; Lerer B; Chisin R Neuroradiology; 1998 Jul; 40(7):428-34. PubMed ID: 9730341 [TBL] [Abstract][Full Text] [Related]
7. Initial methadone dose in treating opiate addiction. Wang RI; Kochar C; Hasegawa AT; Roh BL Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369 [TBL] [Abstract][Full Text] [Related]
8. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals. Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527 [TBL] [Abstract][Full Text] [Related]
9. Hypofrontality and negative symptoms in major depressive disorder. Galynker II; Cai J; Ongseng F; Finestone H; Dutta E; Serseni D J Nucl Med; 1998 Apr; 39(4):608-12. PubMed ID: 9544664 [TBL] [Abstract][Full Text] [Related]
10. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography. Rubin RT; Villanueva-Meyer J; Ananth J; Trajmar PG; Mena I Arch Gen Psychiatry; 1992 Sep; 49(9):695-702. PubMed ID: 1514874 [TBL] [Abstract][Full Text] [Related]
11. SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. van Dyck CH; Rosen MI; Thomas HM; McMahon TJ; Wallace EA; O'Connor PG; Sullivan M; Krystal JH; Hoffer PB; Woods SW Psychiatry Res; 1994 Dec; 55(4):181-91. PubMed ID: 7701033 [TBL] [Abstract][Full Text] [Related]
12. Transient frontal hypoperfusion in Tc-99m hexamethylpropyleneamineoxime single photon emission computed tomography imaging during alcohol withdrawal. Tutus A; Kuğu N; Sofuoğlu S; Nardali M; Simşek A; Karaaslan F; Gönül AS Biol Psychiatry; 1998 Jun; 43(12):923-8. PubMed ID: 9627750 [TBL] [Abstract][Full Text] [Related]
13. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168 [TBL] [Abstract][Full Text] [Related]
14. [Intrasubject comparison of regional cerebral blood flow between N-isopropyl-p-[123I]iodoamphetamine SPECT and 99mTc-hexamethylpropyleneamine oxime SPECT in patients with ischemic cerebrovascular disease]. Isaka Y; Yoshikawa T; Ohe Y; Nakayama H; Abe T; Ashida K; Imaizumi M; Tanaka S Kaku Igaku; 1995 Feb; 32(2):131-8. PubMed ID: 7715098 [TBL] [Abstract][Full Text] [Related]
15. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity. Charney DS; Redmond DE; Galloway MP; Kleber HD; Heninger GR; Murberg M; Roth RH Life Sci; 1984 Sep; 35(12):1263-72. PubMed ID: 6482651 [TBL] [Abstract][Full Text] [Related]
16. [Evaluation of regional cerebral blood flow using 99mTc-ECD SPECT in ethanol dependent patients: pilot study]. Pach D; Hubalewska-Dydejczyk A; Szurkowska M; Kamenczak A; Targosz D; Gawlikowski T; Huszno B; Głowa B Przegl Lek; 2007; 64(4-5):204-7. PubMed ID: 17724867 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Wang GJ; Volkow ND; Fowler JS; Logan J; Abumrad NN; Hitzemann RJ; Pappas NS; Pascani K Neuropsychopharmacology; 1997 Feb; 16(2):174-82. PubMed ID: 9015800 [TBL] [Abstract][Full Text] [Related]
18. Naloxone applied to conjunctiva as a test for physical opiate dependence. Creighton FJ; Ghodse AH Lancet; 1989 Apr; 1(8641):748-50. PubMed ID: 2564564 [TBL] [Abstract][Full Text] [Related]
19. Central representation of phantom limb phenomenon in amputees studied with single photon emission computerized tomography. Liaw MY; You DL; Cheng PT; Kao PF; Wong AM Am J Phys Med Rehabil; 1998; 77(5):368-75. PubMed ID: 9798826 [TBL] [Abstract][Full Text] [Related]
20. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria. Kosten TA; Jacobsen LK; Kosten TR Am J Drug Alcohol Abuse; 1989; 15(3):237-50. PubMed ID: 2763981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]